Search clinical trials for: Rituxan® (rituximab)
Total 16910 results
-
Swedish Medical CenterGenentech, Inc.Completed
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI); Genentech, Inc.TerminatedThrombotic Thrombocytopenic PurpuraUnited States
-
Ohio State University Comprehensive Cancer CenterAstex Pharmaceuticals, Inc.CompletedB-Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)Not yet recruitingClassic Follicular Lymphoma | Follicular Lymphoma With Unusual Cytological Features
-
Emory UniversityGenentech, Inc.Active, not recruitingStage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Unresectable Melanoma | Stage III Melanoma | Stage IIIA Skin Melanoma | Cutaneous Melanoma, Stage III | Cutaneous Melanoma, Stage IVUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicFinland, France, Spain, Portugal, Turkey, United Kingdom, Sweden, Tunisia
-
Dana-Farber Cancer InstituteRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
SecuraBioTerminatedFollicular LymphomaFrance, Italy, Australia, Poland
-
Hoffmann-La RocheNordic Lymphoma GroupCompleted
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterKite, A Gilead Company; Acerta Pharma, LLCRecruitingLymphoma | Mantle Cell LymphomaUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States
-
Incyte CorporationWithdrawn
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Recurrent Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterBiogen; CTI BioPharmaCompleted
-
Ranjana AdvaniGenentech, Inc.CompletedLymphoma | Hodgkin Lymphoma (Category) | Nodular Lymphocyte Predominant Hodgkin LymphomaUnited States
-
Hoffmann-La RocheCompleted
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.Completed
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterTerminatedDiffuse Large B Cell LymphomaUnited States
-
Altor BioScienceTerminatedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomaUnited States
-
PrECOG, LLC.Genentech, Inc.TerminatedIndolent Non-Hodgkin's LymphomaUnited States
-
University of RochesterMillennium Pharmaceuticals, Inc.; CephalonCompletedNon-Hodgkin's LymphomaUnited States
-
Northwestern UniversityRobert H. Lurie Cancer CenterCompletedNon-Hodgkin's LymphomaUnited States
-
M.D. Anderson Cancer CenterRecruitingRefractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Richter Syndrome | Refractory Mantle Cell Lymphoma | Refractory Aggressive B-Cell Non-Hodgkin Lymphoma | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory... and other conditionsUnited States
-
Aptevo TherapeuticsTerminatedChronic Lymphocytic Leukemia | Peripheral T-cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Indolent Adult Non-Hodgkin... and other conditionsUnited States
-
Hoffmann-La RocheBiogenCompletedRheumatoid ArthritisBelgium, Germany, Norway, United Kingdom, United States, Ireland, France, Canada, Israel, Netherlands, Italy
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminated
-
National Institute of Diabetes and Digestive and...Genentech, Inc.; Indiana UniversityCompletedFocal Segmental Glomerulosclerosis (FSGS)United States
-
German Low Grade Lymphoma Study GroupTerminatedIndolent LymphomaGermany
-
M.D. Anderson Cancer CenterActive, not recruitingMantle Cell LymphomaUnited States
-
Washington University School of MedicineAcerta Pharma BVActive, not recruitingMantle Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteHiberCell, Inc.CompletedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomasUnited States
-
University of NebraskaCompleted
-
MEI Pharma, Inc.Kyowa Kirin, Inc.Withdrawn
-
Novartis PharmaceuticalsGlaxoSmithKlineTerminatedNon-Hodgkin's LymphomaChina, United States, Belgium, Czechia, France, Japan, Bulgaria, Canada, Hungary, Peru, Slovakia, South Africa, Ukraine, Korea, Republic of, Puerto Rico, Brazil
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | CCND1 Positive | CCND2 Positive | CCND3 Positive | CD20 Positive | Refractory Mantle Cell LymphomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed
-
Assiut UniversityUnknown
-
Ohio State University Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade... and other conditionsUnited States
-
Hoffmann-La RocheCompleted
-
M.D. Anderson Cancer CenterBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedLymphoma | Leukemia | Lymphoid Malignancies | Disorder Related to Transplantation | Transplantation, Stem CellUnited States
-
M.D. Anderson Cancer CenterBayerCompletedLeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHairy Cell Leukemia | Recurrent Hairy Cell LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAnn Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann... and other conditionsUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)WithdrawnRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Recurrent Burkitt Lymphoma | Refractory Burkitt... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Grade 3a Follicular LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedNodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone... and other conditionsUnited States